AGREEMENT ---------Registration Rights Agreement • November 5th, 2004 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
Exhibit 4.9 CONSULTING AGREEMENT This CONSULTING AGREEMENT is entered into by Provectus Pharmaceuticals, Inc., ("PVCT") an OTC BB NASD regulated public Company; and Dr. Phillip C. Baker (the "Consultant"), effective this 5th day of November, 2003....Consulting Agreement • November 10th, 2004 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 4.3 NEITHER THE OFFER NOR THE SALE OF THIS WARRANT OR THE SHARES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"). EXCEPT AS OTHERWISE SET FORTH HEREIN OR IN A SECURITIES...Warrant Agreement • May 16th, 2005 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 25th, 2016 • Provectus Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August 25, 2016, between Provectus Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
EXHIBIT 4.1 SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT, dated as of _______, 2005, is entered into by and between PROVECTUS PHARMACEUTICALS, INC., a Nevada corporation, with headquarters located at 7327 Oak Ridge Highway, Suite...Securities Purchase Agreement • August 30th, 2005 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 28th, 2013 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of February 22, 2013, between Provectus Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
Exhibit 4.2 THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD OR OFFERED FOR SALE IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES OR...Common Stock Purchase Warrant • January 16th, 2004 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations
AGREEMENT ---------Settlement Agreement • June 26th, 2003 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations
WARRANTWarrant Agreement • October 7th, 2004 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations
Agreement ---------Consulting Agreement • October 1st, 2003 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations
FINAL] ANNEX IV TO SECURITIES PURCHASE AGREEMENT REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT, dated as of November 19, 2003 (this "Agreement"), is made by and between PROVECTUS PHARMACEUTICALS, INC., a Nevada corporation, with...Registration Rights Agreement • January 16th, 2004 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New York
www.duncancapital.net March 1, 2005 Provectus Pharmaceuticals, Inc. 7327 Oak Ridge Highway Suite A Knoxville, TN 37931 Attn: Peter Culpepper, CFO RE: ADVISORY AGREEMENT Dear Mr. Culpepper: This letter confirms the terms upon which Provectus...Advisory Agreement • May 16th, 2005 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 99.1 SUPPLY AGREEMENT This Supply Agreement ("Agreement") is made as of the 1st day of June, 2004 by and between AmericsourceBergen Drug Corporation ("AmerisourceBergen") with an address at 1300 Morris Drive, Chesterbrook, PA 19087-5594 and...Supply Agreement • November 12th, 2004 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • Pennsylvania
INDEMNIFICATION AGREEMENTIndemnification Agreement • July 16th, 2020 • Provectus Biopharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of July 20, 2020, between PROVECTUS Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and Webster Bailey (“Indemnitee”).
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT Securities Purchase Agreement (this "Agreement"), dated as of March 30, 2005, by and among Provectus Pharmaceuticals, Inc., a Nevada corporation, with headquarters located at 7327 Oak Ridge Highway, Suite A,...Securities Purchase Agreement • May 16th, 2005 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New York
Exhibit 4.4 REGISTRATION RIGHTS AGREEMENT Registration Rights Agreement (this "Agreement"), dated as of March 30, 2005, by and among Provectus Pharmaceuticals, Inc., a Nevada corporation, (the "Company") and each of the undersigned (the "Initial...Registration Rights Agreement • May 16th, 2005 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 4.11 WARRANTWarrant Agreement • May 16th, 2005 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations
PROVECTUS BIOPHARMACEUTICALS, INC. Up to $50,000,000 of Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • April 30th, 2014 • Provectus Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York
Provectus Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
WARRANTWarrant Agreement • August 30th, 2005 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 23rd, 2010 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • Nevada
REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of December 22, 2010, by and between PROVECTUS PHARMACEUTICALS, INC., a Nevada corporation, (the "Company"), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").
COMMON STOCK PURCHASE WARRANT PROVECTUS PHARMACEUTICALS, INC.Common Stock Purchase Warrant • December 23rd, 2010 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Lincoln Park Capital Fund, LLC (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after __________, 2010 (the “Initial Exercise Date”) and on or prior to the close of business on the fifth anniversary of the date hereof (the “Termination Date”) but not thereafter, to subscribe for and purchase from Provectus Pharmaceuticals, Inc., a Nevada corporation (the “Company”), up to 500,000 shares (the “Warrant Shares”) of Common Stock The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Buyer Address and Facsimile Number Number of Common Shares Number of Series A Warrant Shares Number of Series B Warrant Shares Number of Series C Warrant Shares Purchase Price Legal Representative’s Address and Facsimile Number Cranshire Capital, L.P....Securities Purchase Agreement • January 13th, 2011 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New York
RecitalsConsulting Agreement • September 17th, 2002 • Provectus Pharmaceuticals Inc • Special industry machinery, nec
EXHIBIT 4.13 WARRANTWarrant Agreement • May 16th, 2005 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 4.1 NEITHER THE OFFER NOR THE SALE OF THIS DEBENTURE OR THE SHARES ISSUABLE UPON THE CONVERSION OF THIS DEBENTURE HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"). EXCEPT AS OTHERWISE SET FORTH HEREIN OR IN A...Debenture Agreement • May 16th, 2005 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 4.16 April 1, 2005 Venture Catalyst, LLC Re: Consulting Agreement -------------------- Dear Venture Catalyst, LLC: This letter sets forth our agreement ("AGREEMENT") with respect to Venture Catalyst, LLC ("VC"), providing consulting services...Consulting Agreement • June 14th, 2005 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
Exhibit 4.2 INVESTOR REGISTRATION RIGHTS AGREEMENT -------------------------------------- THIS REGISTRATION RIGHTS AGREEMENT (this "Agreement") dated as of July 28, 2004, by and among PROVECTUS PHARMACEUTICALS, INC., a Nevada corporation (the...Investor Registration Rights Agreement • October 7th, 2004 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
Exhibit 10.2 STANDBY EQUITY DISTRIBUTION AGREEMENT ------------------------------------- THIS STANDBY EQUITY DISTRIBUTION AGREEMENT (the "Agreement") dated as of July 28, 2004 by and between CORNELL CAPITAL PARTNERS, LP, a Delaware limited partnership...Standby Equity Distribution Agreement • November 10th, 2004 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
PROVECTUS BIOPHARMACEUTICALS, INC. DEALER-MANAGER AGREEMENT January 30, 2017Dealer-Manager Agreement • February 3rd, 2017 • Provectus Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York
The following (this “Agreement”) will confirm our agreement relating to the proposed rights offering (the “Rights Offering”) to be undertaken by Provectus Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), pursuant to which the Company will distribute to holders of record of its common stock, par value $0.001 per share (the “Common Stock”), and holders of the Company’s class of warrants with an exercise price of $0.85 per share expiring June 19, 2020 (“Listed Warrants”) subscription rights (the “Rights”) to purchase up to an aggregate of 19,662,782 units (the “Units”), each Unit consisting of four shares of Common Stock (the “Rights Shares”) and one-half share of Series C Convertible Preferred Stock (the “Preferred Stock”), at a subscription price of $1.00 per Unit in cash (the “Subscription Price”). The Subscription Price is subject to decrease by up to 20% by the Company after consultation with the Dealer-Manager, as described in the Prospectus (as defined herein).
EXHIBIT 4.12 FINDERS FEE AGREEMENT April 19, 2004 This agreement (the "Agreement") is made by and between Provectus Pharmaceuticals, Inc. (the "Company") and Centre Capital Advisors, LLC (the "Finder"). WITNESSETH WHEREAS, the Company seeks accredited...Finder's Fee Agreement • May 16th, 2005 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 4.10 FINANCIAL ADVISORY AND INVESTMENT BANKING AGREEMENT This Agreement is made and entered into as of the 15th day of August 2004 (the "Effective Date") between Network 1 Financial Securities ("Network 1" or the "Consultant") and Provectus...Financial Advisory and Investment Banking Agreement • May 16th, 2005 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New York
ContractWarrant to Purchase Common Stock • January 13th, 2011 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New York
e) "Control" means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting stock or interests, by contract or otherwise. 1Common Share Purchase Warrant • May 16th, 2005 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • Nevada
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 13th, 2014 • Provectus Biopharmaceuticals, Inc. • Pharmaceutical preparations • Tennessee
THIS AGREEMENT made as of this 1st day of July 2013 by and between PROVECTUS PHARMACEUTICALS, INC., a Nevada Corporation with its principal place of business in Knoxville, Tennessee (the “Company”), and Timothy C. Scott, Ph.D. (the “Executive”).
PURCHASE AGREEMENTPurchase Agreement • July 26th, 2013 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New York
PURCHASE AGREEMENT (the “Agreement”), dated as of July 22, 2013, by and between PROVECTUS PHARMACEUTICALS, INC., a Nevada corporation, (the “Company”), and ALPHA CAPITAL ANSTALT (the “Investor”).
